These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20078557)

  • 21. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
    Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
    Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pertussis in Lao PDR: Seroprevalence and disease.
    Kleine D; Billamay S; Chanthavilay P; Mongkhoune S; Keokhamphoui C; Souksakhone C; Nouanthong P; Khamphaphongphane B; Muller CP; Black AP
    Int J Infect Dis; 2020 Jun; 95():282-287. PubMed ID: 32278108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of Immunoglobulin G antibodies against pertussis toxin among asymptomatic medical students in the west of Iran: a cross sectional study.
    Hashemi SH; Ranjbar M; Hajilooi M; Seif-Rabiei MA; Bolandi M; Moghimi J
    BMC Infect Dis; 2009 May; 9():58. PubMed ID: 19426546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transversal sero-epidemiological study of Bordetella pertussis in Tehran, Iran.
    Noel G; Badmasti F; Nikbin VS; Zahraei SM; Madec Y; Tavel D; Aït-Ahmed M; Guiso N; Shahcheraghi F; Taieb F
    PLoS One; 2020; 15(9):e0238398. PubMed ID: 32870922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study.
    Torzsa P; Devadiga R; Tafalla M
    BMC Infect Dis; 2017 Apr; 17(1):242. PubMed ID: 28376739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal.
    Relyveld E; Oato NH; Guérin N; Coursaget P; Huet M; Gupta RK
    Vaccine; 1991 Nov; 9(11):843-50. PubMed ID: 1759508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults.
    Diez-Domingo J; Ballester A; Baldó JM; Planelles MV; Villarroya JV; Alvarez T; Carmen Peidró M; Calero P; Garcés MD; Sorribes I; Graullera M; Jubert A; San-Martín M; González A
    J Infect; 2004 Oct; 49(3):242-7. PubMed ID: 15337342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Contents of antibodies to Bordetella pertussis antigens in patients with rheumatic diseases].
    Kostinov MP; Tarasova AA; Zaĭtsev EM
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (6):61-4. PubMed ID: 18277540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serological evaluation of Bordetella pertussis infection in adults with prolonged cough].
    Sönmez C; Çöplü N; Gözalan A; Yılmaz Ü; Bilekli S; Demirci NY; Biber Ç; Erdoğan Y; Esen B; Çöplü L
    Mikrobiyol Bul; 2016 Jul; 50(3):361-70. PubMed ID: 27525392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children.
    von Linstow ML; Pontoppidan PL; von König CH; Cherry JD; Hogh B
    Eur J Pediatr; 2010 Sep; 169(9):1119-22. PubMed ID: 20373111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
    Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
    Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.
    Fry NK; Litt DJ; Duncan J; Vaghji L; Warrener L; Samuel D; Andrews N; Harnden A; Harrison TG
    J Med Microbiol; 2013 Sep; 62(Pt 9):1281-1289. PubMed ID: 23722435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-related differences in antibody avidities to pertussis toxin and filamentous hemagglutinin in a healthy Japanese population.
    Fumimoto R; Otsuka N; Sunagawa T; Tanaka-Taya K; Kamiya H; Kamachi K
    Vaccine; 2019 Apr; 37(18):2463-2469. PubMed ID: 30930008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of pertussis in Senegal: a prospective study.
    Gaayeb L; Sarr JB; Ndiath MO; Hanon JB; Debrie AS; Seck M; Schacht AM; Remoué F; Hermann E; Riveau G
    PLoS One; 2012; 7(10):e48684. PubMed ID: 23119090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of diphtheria and pertussis immunoglobulin G among children with pneumonia in Ji'nan, China.
    Meng Q; Li L; Shi W; Wang Q; Ding M; Liu Y; Ma X; Yao K
    BMC Pediatr; 2018 Dec; 18(1):383. PubMed ID: 30518371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective multinational serosurveillance study of Bordetella pertussis infection among 10- to 18-year-old Asian children and adolescents.
    Son S; Thamlikitkul V; Chokephaibulkit K; Perera J; Jayatilleke K; Hsueh PR; Lu CY; Balaji V; Moriuchi H; Nakashima Y; Lu M; Yang Y; Yao K; Kim SH; Song JH; Kim S; Kim MJ; Heininger U; Chiu CH; Kim YJ
    Clin Microbiol Infect; 2019 Feb; 25(2):250.e1-250.e7. PubMed ID: 29689428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody Specificity Following a Recent
    Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T
    Front Immunol; 2019; 10():1364. PubMed ID: 31275314
    [No Abstract]   [Full Text] [Related]  

  • 39. Seroprevalence of pertussis in the Gambia: evidence for continued circulation of bordetella pertussis despite high vaccination rates.
    Scott S; van der Sande M; Faye-Joof T; Mendy M; Sanneh B; Barry Jallow F; de Melker H; van der Klis F; van Gageldonk P; Mooi F; Kampmann B
    Pediatr Infect Dis J; 2015 Apr; 34(4):333-8. PubMed ID: 25764094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study.
    Zhang Q; Zheng H; Liu M; Han K; Shu J; Wu C; Xu N; He Q; Luo H
    BMC Infect Dis; 2012 Jun; 12():138. PubMed ID: 22892100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.